Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells.

Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells.

Item
http://www.wikidata.org/entity/Q32107279
The Philadelphia chromosome in leukemogenesisA critical role of CDKN3 in Bcr-Abl-mediated tumorigenesisCytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factorSTI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL.TRAIL recombinant adenovirus triggers robust apoptosis in multidrug-resistant HL-60/Vinc cells preferentially through death receptor DR5Platelet Derived Growth Factor Alpha (PDGFRα) Induces the Activation of Cardiac Fibroblasts by Activating c-KitHOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cellsErythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP.The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer.Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL.BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy.
P2860

Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells.

Item
http://www.wikidata.org/entity/Q32107279
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@ast
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@en
type
label
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@ast
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@en
prefLabel
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@ast
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P921
P1433
P1476
Cotreatment with STI-571 enhan ...... ve human acute leukemia cells.
@en
P2093
P304
P31
P407
P433
P478
P577
P698
P921